DE69133123D1 - Vorrichtung zur transdermalen abgabe von annähernd gesättigten medikamenten mit erhöhtem medikamentenfluss - Google Patents

Vorrichtung zur transdermalen abgabe von annähernd gesättigten medikamenten mit erhöhtem medikamentenfluss

Info

Publication number
DE69133123D1
DE69133123D1 DE69133123T DE69133123T DE69133123D1 DE 69133123 D1 DE69133123 D1 DE 69133123D1 DE 69133123 T DE69133123 T DE 69133123T DE 69133123 T DE69133123 T DE 69133123T DE 69133123 D1 DE69133123 D1 DE 69133123D1
Authority
DE
Germany
Prior art keywords
drugs
transdermal delivery
increased drug
drug flow
testosterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69133123T
Other languages
English (en)
Other versions
DE69133123T2 (de
Inventor
Charles D Ebert
Dinesh Patel
Werner Heiber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Theratech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/626,685 external-priority patent/US5164190A/en
Application filed by Theratech Inc filed Critical Theratech Inc
Application granted granted Critical
Publication of DE69133123D1 publication Critical patent/DE69133123D1/de
Publication of DE69133123T2 publication Critical patent/DE69133123T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
DE69133123T 1990-12-11 1991-12-11 Vorrichtung zur transdermalen abgabe von annähernd gesättigten medikamenten mit erhöhtem medikamentenfluss Expired - Lifetime DE69133123T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/626,685 US5164190A (en) 1990-12-11 1990-12-11 Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
US07/652,127 US5152997A (en) 1990-12-11 1991-02-07 Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
PCT/US1991/009408 WO1992010231A1 (en) 1990-12-11 1991-12-11 Subsaturated transdermal drug delivery device exhibiting enhanced drug flux

Publications (2)

Publication Number Publication Date
DE69133123D1 true DE69133123D1 (de) 2002-11-07
DE69133123T2 DE69133123T2 (de) 2003-02-06

Family

ID=27090229

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69133123T Expired - Lifetime DE69133123T2 (de) 1990-12-11 1991-12-11 Vorrichtung zur transdermalen abgabe von annähernd gesättigten medikamenten mit erhöhtem medikamentenfluss

Country Status (14)

Country Link
US (1) US5152997A (de)
EP (1) EP0562041B1 (de)
JP (3) JP3068187B2 (de)
KR (1) KR100200002B1 (de)
AT (1) ATE225166T1 (de)
AU (1) AU651165B2 (de)
CA (1) CA2098195C (de)
DE (1) DE69133123T2 (de)
DK (1) DK0562041T3 (de)
ES (1) ES2179820T3 (de)
HK (1) HK1013803A1 (de)
IE (1) IE914300A1 (de)
PT (1) PT99751B (de)
WO (1) WO1992010231A1 (de)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
WO1993023025A1 (en) * 1992-05-13 1993-11-25 Alza Corporation Transdermal administration of oxybutynin
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
US5333621A (en) * 1993-05-28 1994-08-02 Eric Denzer Condom with transdermal vasodilator
US5460820B1 (en) * 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
DE69426517D1 (de) * 1993-10-29 2001-02-08 Ammonia Casale Sa Verfahren zur Nachrüstung eines heterogenen exothermischen Synthesereaktors
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
US5952000A (en) * 1996-10-30 1999-09-14 Theratech, Inc. Fatty acid esters of lactic acid salts as permeation enhancers
AU735944B2 (en) * 1997-02-28 2001-07-19 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of testosterone
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
US8765177B2 (en) 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
ES2318233T3 (es) * 1997-11-10 2009-05-01 Strakan International Limited Sistemas mejoradores de la penetracion y reductores de la irritacion que comprenden testosterona.
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6726673B1 (en) * 1999-05-24 2004-04-27 Zars, Inc. Methods and apparatus for improved administration of testosterone pharmaceuticals
GB9828480D0 (en) * 1998-12-24 1999-02-17 Dermatech Limited Transdermal drug delivery system
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
SK18212001A3 (sk) 1999-06-11 2002-04-04 Watson Pharmaceuticals, Inc. Kit na zlepšenie zdravotného stavu žien
US7083781B2 (en) * 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
FR2801507B1 (fr) * 1999-11-30 2003-06-27 Pf Medicament Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations
US6562369B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
EP2322170A1 (de) * 2000-04-26 2011-05-18 Watson Pharmaceuticals, Inc. Minimierung unerwünschter Ereignisse im Zusammenhang mit Oxybutyninbehandlungen
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US20030124177A1 (en) * 2000-04-26 2003-07-03 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
KR100403051B1 (ko) * 2000-07-25 2003-10-23 일양약품주식회사 음낭 외 피부에 적용가능한 남성호르몬 경피흡수 패취제
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
AU2001286995B2 (en) * 2000-08-30 2006-11-30 Besins Healthcare Luxembourg Sarl Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
JP2004507511A (ja) * 2000-08-30 2004-03-11 ユニメッド・ファーマシューティカルズ・インコーポレーテッド 女性におけるテストステロンおよび近縁ステロイド濃度を増大させる方法
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
WO2002055020A2 (en) * 2000-12-11 2002-07-18 Testocreme Llc Topical testosterone formulations and associated methods
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
WO2002074286A1 (en) * 2001-03-16 2002-09-26 Alza Corporation Transdermal patch for administering fentanyl
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
US20040072810A1 (en) 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
ATE439829T1 (de) * 2001-12-07 2009-09-15 Besins Int Belgique Gel oder lísung enthaltend dihydrotestosterone, deren herstellungsverfahren und verwendung
US7921999B1 (en) * 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
UA80964C2 (en) * 2002-03-15 2007-11-26 Unimed Pharmaceuticals Inc Method for treating depression and kit therefor
IL152575A (en) * 2002-10-31 2008-12-29 Transpharma Medical Ltd A skin-to-skin transmission system of water-insoluble drugs
IL152573A (en) * 2002-10-31 2009-11-18 Transpharma Medical Ltd A system for the transmission through the skin of a medical preparation against vomiting and nausea
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050025833A1 (en) * 2003-07-16 2005-02-03 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
US10137135B2 (en) 2005-08-15 2018-11-27 Allergan Sales, Llc Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
DE102005044228A1 (de) * 2005-09-16 2007-04-05 Universität Stuttgart Verbindungsvorrichtung mit einem Verbindungselement und einem Zugmittel sowie Verfahren zur Herstellung einer Verbindung
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
US8383149B2 (en) * 2005-09-23 2013-02-26 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
DK2450041T3 (en) 2005-10-12 2018-11-19 Unimed Pharmaceuticals Llc Enhanced testosterone gel for use in the treatment of hypogonadism
KR101156751B1 (ko) * 2006-09-21 2012-07-03 고쿠리츠다이가쿠호진 도호쿠다이가쿠 리지드 플렉서블 프린트 배선판 및 리지드 플렉서블 프린트배선판의 제조방법
CN101902996B (zh) * 2007-10-15 2014-11-26 阿尔扎公司 芬太尼的一天更换一次透皮施用
FR2924942B1 (fr) * 2007-12-14 2012-06-15 Pf Medicament Compositions pharmaceutiques transcutanees contenant une hormone steroidienne
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
JP5816636B2 (ja) 2010-03-17 2015-11-18 ノバリック ゲーエムベーハー 眼圧上昇の治療のための医薬組成物
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2012160179A2 (en) 2011-05-25 2012-11-29 Novaliq Gmbh Topical pharmaceutical composition based on semifluorinated alkanes
PT2895144T (pt) 2012-09-12 2017-02-22 Novaliq Gmbh Composições de alcano semifluorado
CN105744983B (zh) * 2013-08-12 2019-12-27 纳米医学系统公司 用于缓释在增溶剂中的低水溶性治疗剂的装置和方法
US8785426B1 (en) * 2013-12-13 2014-07-22 Upsher-Smith Laboratories, Inc. Testosterone gel compositions and related methods
EP2944324A1 (de) * 2014-05-13 2015-11-18 LTS LOHMANN Therapie-Systeme AG Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
PL3355990T3 (pl) 2015-09-30 2019-11-29 Novaliq Gmbh Semifluorowane związki oraz ich kompozycje
US10493049B2 (en) 2016-02-10 2019-12-03 Niracle LLC Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
CA3036306A1 (en) 2016-09-23 2018-03-29 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
WO2019063551A1 (en) 2017-09-27 2019-04-04 Novaliq Gmbh OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES
US11896559B2 (en) 2017-10-04 2024-02-13 Novaliq Gmbh Opthalmic compositions comprising F6H8
EP3856128B1 (de) 2018-09-27 2023-06-07 Dermaliq Therapeutics, Inc. Topische sonnenschutzmittelformulierung
CN112823020A (zh) 2018-10-12 2021-05-18 诺瓦利克有限责任公司 用于治疗干眼病的眼用组合物
EP4308088A1 (de) 2021-11-08 2024-01-24 Weiyong Li Transdermales arzneimittelabgabesystem zur abgabe eines arzneimittels an einen patienten

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
EP0267617B1 (de) * 1986-11-14 1992-06-24 Theratech, Inc. Erhöhung des Penetrationsvermögens mittels eines aus die Zellhülle verändernden Substanzen und kurzkettigen Alkoholen bestehenden binären Systems
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US4820720A (en) * 1987-08-24 1989-04-11 Alza Corporation Transdermal drug composition with dual permeation enhancers
PT90820B (pt) * 1988-06-14 1995-05-31 Alza Corp Dispositivo de libertacao transdermica sub-saturado
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US4906963A (en) * 1989-03-01 1990-03-06 Gould, Inc. Externally mounted blown fuse indicator
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith

Also Published As

Publication number Publication date
CA2098195A1 (en) 1992-06-11
DK0562041T3 (da) 2002-10-28
KR930703038A (ko) 1993-11-29
KR100200002B1 (ko) 1999-06-15
DE69133123T2 (de) 2003-02-06
ATE225166T1 (de) 2002-10-15
JP3068187B2 (ja) 2000-07-24
AU651165B2 (en) 1994-07-14
JPH06503252A (ja) 1994-04-14
CA2098195C (en) 1996-10-29
PT99751B (pt) 1996-06-28
JP2000153001A (ja) 2000-06-06
JP2002249425A (ja) 2002-09-06
EP0562041A4 (en) 1995-09-13
ES2179820T3 (es) 2003-02-01
WO1992010231A1 (en) 1992-06-25
EP0562041A1 (de) 1993-09-29
PT99751A (pt) 1994-01-31
US5152997A (en) 1992-10-06
IE914300A1 (en) 1992-06-17
HK1013803A1 (en) 1999-09-10
AU9175791A (en) 1992-07-08
EP0562041B1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
DE69133123D1 (de) Vorrichtung zur transdermalen abgabe von annähernd gesättigten medikamenten mit erhöhtem medikamentenfluss
DK0494972T3 (da) Brusedosisform samt fremgangsmåde til administration heraf
DE69326848T2 (de) Oxybutynin zur transdermalen Verabreichung
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
ATE142116T1 (de) Durch körperliche aktivität gesteuerte vorrichtung zur iontophoretischen verabreichung von medikamenten
DE69414502D1 (de) Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen
ATE89755T1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
ATE169816T1 (de) Verwendung von melatonin in niedrigen oralen dosen zum herbeiführen von schlaf
NO951592D0 (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
DE3872109T2 (de) Vorrichtung zur transkutanen wirkstoffabgabe mit doppeltem durchgangsverstaerker.
FI95539C (fi) Transdermaalinen järjestelmä, sen valmistusmenetelmä ja käyttö
ATE361073T1 (de) Neue formulierungen zur transdermalen verabreichung von pergolid
ATE214946T1 (de) Zusammensetzungen zur penetrationsförderung in der haut durch gebrauch von acryllactylaten
ATE77962T1 (de) Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
DE59603597D1 (de) Therapeutische zubereitung zur transdermalen applikation von wirkstoffen durch die haut
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
ATE264672T1 (de) Vorrichtung und verwendung zur steigerung der transdermalen permeation von arzneistoffen
DE3880212D1 (de) Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.
YU46705B (sh) Postupak za proizvodnju matrice za ispuštanje i/ili doziranje doziranje lekovite aktivne materije
KR920011502A (ko) 인체 신경계의 통증을 치료할 수 있는 부자이중탕(附子理中湯)의 개량된 한방치료제 물질
DE69430807D1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
ATE88092T1 (de) Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.
NO941314L (no) Anordning for transdermal administrering av melatonin
ATE87423T1 (de) Vorrichtung zur ausrichtung von fischen in bezug auf den stand von abdomen und dorsum.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition